These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17123290)

  • 41. The role of liver transplantation in the management of portal hypertension.
    Sudan DL; Shaw BW
    Clin Liver Dis; 1997 May; 1(1):115-20, xii. PubMed ID: 15562672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transjugular intrahepatic portosystemic stent-shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin.
    Nolte W; Canelo R; Figulla HR; Kersten J; Sattler B; Münke H; Hartmann H; Ringe B; Ramadori G
    Z Gastroenterol; 1998 Feb; 36(2):159-64. PubMed ID: 9544499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Role of transjugular intrahepatic portosystemic stents (TIPS) in the prevention of recurrent bleeding due to portal hypertension].
    Bureau C; Péron JM; Otal P; Vinel JP
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):587-9. PubMed ID: 12910221
    [No Abstract]   [Full Text] [Related]  

  • 44. Surgery versus transjugular intrahepatic portal systemic shunt in the treatment of severe variceal bleeding.
    Henderson JM
    Clin Liver Dis; 2006 Aug; 10(3):599-612, ix. PubMed ID: 17162230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transjugular intrahepatic portosystemic shunt.
    Burroughs AK; Patch D
    Semin Liver Dis; 1999; 19(4):457-73. PubMed ID: 10643629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transjugular intrahepatic portosystemic stent-shunt in the management of gastric and ectopic varices.
    Tripathi D; Jalan R
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1155-60. PubMed ID: 17033434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Recurrent bleeding from colonic varices in portal hypertension. The successful prevention of recurrence by the implantation of a transjugular intrahepatic stent-shunt (TIPS)].
    Allgaier HP; Ochs A; Haag K; Hauenstein KH; Tittor W; Rössle M; Blum HE
    Dtsch Med Wochenschr; 1995 Dec; 120(51-52):1773-6. PubMed ID: 8549262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transjugular intrahepatic portosystemic shunt--role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax.
    LaBerge JM
    Clin Liver Dis; 2006 Aug; 10(3):583-98, ix. PubMed ID: 17162229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrahepatic vascular shunting for portal hypertension: early experience with the transjugular intrahepatic porto-systemic shunt.
    Rogers CG; Paolini RM; O'Leary JP
    Am Surg; 1994 Feb; 60(2):114-7. PubMed ID: 8304641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indications and contraindications.
    Brown RS; Lake JR
    Adv Intern Med; 1997; 42():485-504. PubMed ID: 9048128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cirrhosis: caring for patients with end-stage liver failure.
    Kelso LA
    Nurse Pract; 2008 Jul; 33(7):24-30; quiz 30-1. PubMed ID: 18600168
    [No Abstract]   [Full Text] [Related]  

  • 52. Liver retransplantation with cavoportal hemitransposition after percutaneous mesocaval shunt creation.
    Kobe A; Dutkowski P; Müllhaupt B; Clavien PA; Pfammatter T
    Liver Transpl; 2016 Aug; 22(8):1154-8. PubMed ID: 27096231
    [No Abstract]   [Full Text] [Related]  

  • 53. Involution of Portal Hypertensive Gastric and Duodenal Polyps Following Liver Transplantation.
    Te HS; Renz J; Fimmel C
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):e77-e78. PubMed ID: 30081011
    [No Abstract]   [Full Text] [Related]  

  • 54. MELD exception for liver transplantation in portopulmonary hypertension: current implementation and future considerations.
    Porres-Aguilar M; Bartolome SD; Duarte-Rojo A
    Ann Hepatol; 2014; 13(6):719-21. PubMed ID: 25332257
    [No Abstract]   [Full Text] [Related]  

  • 55. Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome.
    Dumortier J; Bizollon T; Scoazec JY; Chevallier M; Bancel B; Berger F; Ducerf C; Claudel-Bonvoisin S; Paliard P; Boillot O; Trepo C
    Scand J Gastroenterol; 2001 Apr; 36(4):417-22. PubMed ID: 11336168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proceedings of the MESSAGE Meeting: MELD (model for end-stage liver disease) Exception Study Group. March 1-2, 2006. Chicago, Illinois, USA.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S85-136. PubMed ID: 20480943
    [No Abstract]   [Full Text] [Related]  

  • 57. Abdominal etiologies of pleural effusion.
    Karki A; Riley L; Mehta HJ; Ataya A
    Dis Mon; 2019 Apr; 65(4):95-103. PubMed ID: 30274930
    [No Abstract]   [Full Text] [Related]  

  • 58. Splenectomy and auxiliary liver transplantation.
    Kesen X; Nanhai S; Yuxin C; Xihong J; Xuting Z; Xueying S; Nan Z; Feng X; Xusheng J; Zongli Z; Jinbo J; Min Z; Yongjun Y
    Transplant Proc; 2000 Nov; 32(7):2308-9. PubMed ID: 11120177
    [No Abstract]   [Full Text] [Related]  

  • 59. Overview of liver transplantation for the perfusionist.
    Lopez RR; Wright JK; Donovan KL; Pinson CW
    J Extra Corpor Technol; 1992; 24(2):26-32. PubMed ID: 10147905
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinics and Research in Hepatology and Gastroenterology. Editorial.
    Eyraud D
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):151-2. PubMed ID: 25656981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.